Observation of clinical efficacy of intrauterine infusion of Danhong injection in adjuvant treatment of intrauterine adhesions

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. The diagnosis is confirmed by hysteroscopy as intrauterine adhesions (according to the classification standard of European Gynecological Endoscopy Association);
•2. Women aged 18-40 years;
•3. The sex hormone test is normal;
•4. The menstrual cycle is normal, and the menstrual volume is significantly less than 1/2 of the previous one, or less than 30ml (menstrual blood loss diagram method);
•5. 3 months before the treatment, have not used any hormone drugs, have not used IUD for contraception;
•6. Non-pregnant state.

•1. Persons who are allergic to the drugs used in this test;
•2. Congenital defects and deformities of the reproductive system;
•3. Persons with genital tuberculosis;
•4. Mentally ill patients;
•5. Combined with serious diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, the operator cannot cooperate to complete the research plan, including patients with a history of infectious diseases, mental illness and other diseases.

发起方

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine